Advanced search
1 file | 849.92 KB Add to list

In utero exposure to Azathioprine in autoimmune disease : where do we stand?

Author
Organization
Keywords
SYSTEMIC-LUPUS-ERYTHEMATOSUS, MODIFYING ANTIRHEUMATIC DRUGS, INFLAMMATORY-BOWEL-DISEASE, INTERSTITIAL LUNG-DISEASE, CHILDREN BORN, PREGNANCY OUTCOMES, NEUROPSYCHOLOGICAL DEVELOPMENT, EULAR RECOMMENDATIONS, RHEUMATIC-DISEASES, IMMUNE FUNCTION

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 849.92 KB

Citation

Please use this url to cite or link to this publication:

MLA
Belizna, C., et al. “In Utero Exposure to Azathioprine in Autoimmune Disease : Where Do We Stand?” AUTOIMMUNITY REVIEWS, vol. 19, no. 9, 2020, doi:10.1016/j.autrev.2020.102525.
APA
Belizna, C., Meroni, P., Shoenfeld, Y., Devreese, K., Aliotaj-Reig, J., Esteve-Valverde, E., … Andreoli, L. (2020). In utero exposure to Azathioprine in autoimmune disease : where do we stand? AUTOIMMUNITY REVIEWS, 19(9). https://doi.org/10.1016/j.autrev.2020.102525
Chicago author-date
Belizna, C, PL Meroni, Y Shoenfeld, Katrien Devreese, J Aliotaj-Reig, E Esteve-Valverde, C Chighizola, et al. 2020. “In Utero Exposure to Azathioprine in Autoimmune Disease : Where Do We Stand?” AUTOIMMUNITY REVIEWS 19 (9). https://doi.org/10.1016/j.autrev.2020.102525.
Chicago author-date (all authors)
Belizna, C, PL Meroni, Y Shoenfeld, Katrien Devreese, J Aliotaj-Reig, E Esteve-Valverde, C Chighizola, F Pregnolato, H Cohen, C Fassot, PM Mattera, P Peretti, A Levy, L Bernard, M Saiet, L Lagarce, M Briet, M Rivière, I Pellier, G Gascoin, J Rakotonjanahary, MO Borghi, L Stojanovich, A Djokovic, N Stanisavljevic, R Bromley, E Elefant-Amoura, N Bahi Buisson, T Pindi Sala, H Kelchtermans, A Makatsariya, V Bidsatze, J Khizroeva, JO Latino, S Udry, D Henrion, L Loufrani, AL Guihot, C Muchardt, M Hasan, MN Ungeheur, J Voswinkel, L Damian, I Pabinger, J Gebhart, R Lopez Pedrera, JW Cohen Tervaert, A Tincani, and L Andreoli. 2020. “In Utero Exposure to Azathioprine in Autoimmune Disease : Where Do We Stand?” AUTOIMMUNITY REVIEWS 19 (9). doi:10.1016/j.autrev.2020.102525.
Vancouver
1.
Belizna C, Meroni P, Shoenfeld Y, Devreese K, Aliotaj-Reig J, Esteve-Valverde E, et al. In utero exposure to Azathioprine in autoimmune disease : where do we stand? AUTOIMMUNITY REVIEWS. 2020;19(9).
IEEE
[1]
C. Belizna et al., “In utero exposure to Azathioprine in autoimmune disease : where do we stand?,” AUTOIMMUNITY REVIEWS, vol. 19, no. 9, 2020.
@article{8659497,
  articleno    = {102525},
  author       = {Belizna, C and Meroni, PL and Shoenfeld, Y and Devreese, Katrien and Aliotaj-Reig, J and Esteve-Valverde, E and Chighizola, C and Pregnolato, F and Cohen, H and Fassot, C and Mattera, PM and Peretti, P and Levy, A and Bernard, L and Saiet, M and Lagarce, L and Briet, M and Rivière, M and Pellier, I and Gascoin, G and Rakotonjanahary, J and Borghi, MO and Stojanovich, L and Djokovic, A and Stanisavljevic, N and Bromley, R and Elefant-Amoura, E and Bahi Buisson, N and Pindi Sala, T and Kelchtermans, H and Makatsariya, A and Bidsatze, V and Khizroeva, J and Latino, JO and Udry, S and Henrion, D and Loufrani, L and Guihot, AL and Muchardt, C and Hasan, M and Ungeheur, MN and Voswinkel, J and Damian, L and Pabinger, I and Gebhart, J and Lopez Pedrera, R and Cohen Tervaert, JW and Tincani, A and Andreoli, L},
  issn         = {1568-9972},
  journal      = {AUTOIMMUNITY REVIEWS},
  keywords     = {SYSTEMIC-LUPUS-ERYTHEMATOSUS,MODIFYING ANTIRHEUMATIC DRUGS,INFLAMMATORY-BOWEL-DISEASE,INTERSTITIAL LUNG-DISEASE,CHILDREN BORN,PREGNANCY OUTCOMES,NEUROPSYCHOLOGICAL DEVELOPMENT,EULAR RECOMMENDATIONS,RHEUMATIC-DISEASES,IMMUNE FUNCTION},
  language     = {eng},
  number       = {9},
  pages        = {13},
  title        = {In utero exposure to Azathioprine in autoimmune disease : where do we stand?},
  url          = {http://dx.doi.org/10.1016/j.autrev.2020.102525},
  volume       = {19},
  year         = {2020},
}

Altmetric
View in Altmetric
Web of Science
Times cited: